Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
the risk of progression to a symptomatic disease. (MGUS diagnosis) progression risk is approximately 1% per year, and SMM has a risk of progression of 10% for the first 5 years which tapers off over time. Hi
Continue reading“Non-IgM MGUS is considered a preneoplastic condition with an annual risk of progression of approximately 1%. Risk of progression is increased when M protein greater than or equal to 15 g/L and with
Continue readingSadly, from a diagnosis standpoint, pre-myeloma conditions are viewed as a sort of red-headed stepchild to multiple myeloma. Meaning, oncology focuses on tests for monoclonal proteins and how they might
Continue readingMonoclonal Gammopathy of Undetermined Significance aka MGUS is not cancer. It is considered to be a “blood disorder” or pre-multiple myeloma. Hello David: Great work you are doing to get us
Continue reading